Traws Pharma Ownership | Who Owns Traws Pharma?
Traws Pharma Ownership Summary
Traws Pharma is owned by 22.41% institutional investors, 13.13% insiders, and 64.46% retail investors. Orbimed advisors is the largest institutional shareholder, holding 10.40% of TRAW shares.
TRAW Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | Traws Pharma | 22.41% | 13.13% | 64.46% |
| Sector | Healthcare Stocks | 42.53% | 10.81% | 46.67% |
| Industry | Biotech Stocks | 45.24% | 10.75% | 44.01% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Orbimed advisors | 605.53K | 10.40% | $1.12M |
| Adage capital partners gp | 330.00K | 5.67% | $610.50K |
| Vestal point capital, lp | 150.00K | 2.58% | $277.50K |
| Vanguard group | 87.26K | 1.50% | $161.43K |
| Geode capital management | 43.44K | 0.75% | $80.37K |
| Ikarian capital | 28.49K | 0.49% | $52.71K |
| Two sigma investments, lp | 22.02K | 0.38% | $40.73K |
| Hrt financial lp | 12.57K | 0.22% | $23.00K |
| Xtx topco | 10.71K | 0.18% | $19.81K |
| Blackrock funding, inc. /de | 9.96K | 0.17% | $18.42K |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| Orbimed advisors | 605.53K | 0.03% | $1.12M |
| Vestal point capital, lp | 150.00K | 0.01% | $277.50K |
| Ikarian capital | 28.49K | 0.01% | $52.71K |
| Adage capital partners gp | 330.00K | 0.00% | $610.50K |
| Xtx topco | 10.71K | 0.00% | $19.81K |
| Two sigma investments, lp | 22.02K | 0.00% | $40.73K |
| Hrt financial lp | 12.57K | 0.00% | $23.00K |
| Vermillion & white wealth management group | 96.00 | 0.00% | $142.00 |
| Boothbay fund management | - | - | - |
| Two sigma securities | - | - | - |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Vanguard group | 87.26K | - | 74.09K |
| Hrt financial lp | 12.57K | 0.00% | 12.57K |
| Xtx topco | 10.71K | 0.00% | 10.71K |
| Geode capital management | 43.44K | - | 7.71K |
| Two sigma investments, lp | 22.02K | 0.00% | 5.96K |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Alyeska investment group | - | - | -52.63K |
| Boothbay fund management | - | - | -33.30K |
| Two sigma securities | - | - | -17.17K |
| Ubs group | 6.00 | - | -3.00K |
| Tower research capital llc (trc) | - | - | -706.00 |
New Positions
| Holder | Shares | % Assets | Change | Value |
|---|---|---|---|---|
| Hrt financial lp | 12.57K | 0.00% | 12.57K | $23.00K |
| Xtx topco | 10.71K | 0.00% | 10.71K | $19.81K |
| Assetmark | 2.00 | - | 2.00 | $4.00 |
Sold Out
| Holder | Change |
|---|---|
| Raymond james financial | -102.00 |
| Tower research capital llc (trc) | -706.00 |
| Two sigma securities | -17.17K |
| Boothbay fund management | -33.30K |
| Alyeska investment group | -52.63K |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep 30, 2025 | 17 | -10.53% | 1,304,499 | 3.25% | 22 | 4.76% | 9 | 50.00% | 1 | -80.00% |
| Jun 30, 2025 | 19 | - | 1,263,487 | -27.06% | 21 | 46.34% | 6 | -50.00% | 5 | 25.00% |
| Mar 31, 2025 | 19 | 5.56% | 1,732,327 | 48.01% | 6 | 32.01% | 12 | - | 4 | 100.00% |
| Dec 31, 2024 | 18 | 80.00% | 1,170,406 | 81.08% | 4 | 70.91% | 12 | 20.00% | 2 | - |
| Sep 30, 2024 | 10 | - | 646,356 | - | 2 | - | 10 | - | - | - |
Recent Insider Transactions
| Date | Name | Role | Activity | Value |
|---|---|---|---|---|
| Dec 29, 2024 | ORBIMED ADVISORS LLC | - | Buy | $963.48 |
| Dec 29, 2024 | ORBIMED ADVISORS LLC | - | Buy | $1.29M |
| Dec 29, 2024 | CAUTREELS WERNER | Chief Executive Officer | Buy | $963.48 |
| Dec 29, 2024 | CAUTREELS WERNER | Chief Executive Officer | Buy | $1.29M |
| Dec 29, 2024 | TPAV, LLC | - | Buy | $963.48 |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2025 Q1 | - | - |
| 2024 Q4 | 8 | - |
| 2024 Q3 | - | - |
| 2024 Q2 | - | - |
TRAW Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools